ITRM20020562A1 - Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza. - Google Patents

Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.

Info

Publication number
ITRM20020562A1
ITRM20020562A1 IT000562A ITRM20020562A ITRM20020562A1 IT RM20020562 A1 ITRM20020562 A1 IT RM20020562A1 IT 000562 A IT000562 A IT 000562A IT RM20020562 A ITRM20020562 A IT RM20020562A IT RM20020562 A1 ITRM20020562 A1 IT RM20020562A1
Authority
IT
Italy
Prior art keywords
resveratrol
preparation
treatment
virus infections
useful drug
Prior art date
Application number
IT000562A
Other languages
English (en)
Inventor
Enrico Garaci
Anna Teresa Palamara
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT000562A priority Critical patent/ITRM20020562A1/it
Priority to KR1020057007230A priority patent/KR101060331B1/ko
Priority to AU2003279551A priority patent/AU2003279551A1/en
Priority to PCT/IT2003/000626 priority patent/WO2004041260A1/en
Priority to EP03772659A priority patent/EP1567137B1/en
Priority to AT03772659T priority patent/ATE381929T1/de
Priority to DE60318327T priority patent/DE60318327T2/de
Priority to JP2004549541A priority patent/JP4589118B2/ja
Priority to PT03772659T priority patent/PT1567137E/pt
Priority to CA2504872A priority patent/CA2504872C/en
Priority to ES03772659T priority patent/ES2295660T3/es
Priority to MXPA05004628A priority patent/MXPA05004628A/es
Priority to DK03772659T priority patent/DK1567137T3/da
Priority to US10/533,942 priority patent/US8431617B2/en
Priority to PL377557A priority patent/PL217628B1/pl
Priority to SI200331094T priority patent/SI1567137T1/sl
Priority to TW092129780A priority patent/TWI337863B/zh
Priority to ARP030104047A priority patent/AR041891A1/es
Publication of ITRM20020562A1 publication Critical patent/ITRM20020562A1/it
Priority to CY20081100281T priority patent/CY1107302T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT000562A 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza. ITRM20020562A1 (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
CA2504872A CA2504872C (en) 2002-11-06 2003-10-14 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
ES03772659T ES2295660T3 (es) 2002-11-06 2003-10-14 Uso de resveratrol en la preparacion de un medicamento util para el tratamiento de infecciones por el virus influenza.
PCT/IT2003/000626 WO2004041260A1 (en) 2002-11-06 2003-10-14 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
EP03772659A EP1567137B1 (en) 2002-11-06 2003-10-14 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
AT03772659T ATE381929T1 (de) 2002-11-06 2003-10-14 Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe
DE60318327T DE60318327T2 (de) 2002-11-06 2003-10-14 Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe
JP2004549541A JP4589118B2 (ja) 2002-11-06 2003-10-14 インフルエンザウイルス感染の治療に有用な医薬の調製のためのリスベラトロールの使用
PT03772659T PT1567137E (pt) 2002-11-06 2003-10-14 Utilização de resveratrol para a preparação de um medicamento útil para o tratamento de infecções por vírus da influenza
KR1020057007230A KR101060331B1 (ko) 2002-11-06 2003-10-14 인플루엔자 바이러스 감염의 치료에 유용한 약제의 제조를위한 레스베라트롤의 용도
AU2003279551A AU2003279551A1 (en) 2002-11-06 2003-10-14 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
MXPA05004628A MXPA05004628A (es) 2002-11-06 2003-10-14 Uso de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones del virus de influenza.
DK03772659T DK1567137T3 (da) 2002-11-06 2003-10-14 Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner
US10/533,942 US8431617B2 (en) 2002-11-06 2003-10-14 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
PL377557A PL217628B1 (pl) 2002-11-06 2003-10-14 Zastosowanie resweratrolu do wytwarzania leku wywierającego działanie inhibitorowe na replikację wirusa grypy do zapobiegania i/lub leczenia infekcji wywołanej wirusem grypy
SI200331094T SI1567137T1 (sl) 2002-11-06 2003-10-14 Uporaba resveratrola za pripravo zdravila za uporabo pri zdravljenju infekcij z virusom influence
TW092129780A TWI337863B (en) 2002-11-06 2003-10-27 Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections
ARP030104047A AR041891A1 (es) 2002-11-06 2003-11-05 Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza
CY20081100281T CY1107302T1 (el) 2002-11-06 2008-03-12 Χρηση ρεσβερατρολης για την παρασκευη ενος φαρμακου που ειναι χρησιμο για τη θεραπεια λοιμωξεων απο τον ιο της γριπης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.

Publications (1)

Publication Number Publication Date
ITRM20020562A1 true ITRM20020562A1 (it) 2004-05-07

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.

Country Status (18)

Country Link
US (1) US8431617B2 (it)
EP (1) EP1567137B1 (it)
JP (1) JP4589118B2 (it)
KR (1) KR101060331B1 (it)
AR (1) AR041891A1 (it)
AT (1) ATE381929T1 (it)
AU (1) AU2003279551A1 (it)
CA (1) CA2504872C (it)
CY (1) CY1107302T1 (it)
DE (1) DE60318327T2 (it)
DK (1) DK1567137T3 (it)
ES (1) ES2295660T3 (it)
IT (1) ITRM20020562A1 (it)
MX (1) MXPA05004628A (it)
PL (1) PL217628B1 (it)
PT (1) PT1567137E (it)
TW (1) TWI337863B (it)
WO (1) WO2004041260A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951285A2 (en) * 2005-11-18 2008-08-06 Ares Trading S.A. Interferon in influenza
EP2268272A2 (en) * 2008-03-06 2011-01-05 Mount Sinai School of Medicine of New York University Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
WO2010053949A1 (en) * 2008-11-04 2010-05-14 Metaproteomics, Llc Phytochemical compositions and methods for activating amp-kinase
WO2010123527A2 (en) * 2008-12-19 2010-10-28 The Regents Of The University Of California Use of epidermal growth factor inhibitors in the treatment of viral infection
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
WO2011150413A1 (en) 2010-05-28 2011-12-01 Mount Sinai School Of Medicine Antiviral compounds and uses thereof
US9453017B2 (en) * 2011-09-30 2016-09-27 Vanderbilt University Antiviral therapies with phospholipase D inhibitors
EP2952209B1 (en) 2014-06-04 2018-03-28 Alfasigma S.p.A. Homogeneous formulations comprising omega-3 polyunsaturated fatty acids (n-3 PUFA) and resveratrol for oral administration
ES2615630T3 (es) 2014-06-04 2017-06-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Formulaciones sólidas que contienen resveratrol y ácidos grasos poliinsaturados omega-3 (n-3 PUFA)
EP3120842A1 (en) 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
EP4132277A4 (en) 2020-04-05 2024-09-18 Mong, Michael Systems and methods for treating coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es) * 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
AU765724B2 (en) * 1999-08-13 2003-09-25 University Of Maryland Biotechnology Institute Compositions for treating viral infections, and methods therefor

Also Published As

Publication number Publication date
DE60318327T2 (de) 2008-12-18
JP4589118B2 (ja) 2010-12-01
TW200501935A (en) 2005-01-16
DK1567137T3 (da) 2008-04-28
DE60318327D1 (de) 2008-02-07
CY1107302T1 (el) 2012-11-21
PL377557A1 (pl) 2006-02-06
US20050239906A1 (en) 2005-10-27
ATE381929T1 (de) 2008-01-15
KR20050071627A (ko) 2005-07-07
EP1567137A1 (en) 2005-08-31
AU2003279551A1 (en) 2004-06-07
AR041891A1 (es) 2005-06-01
PL217628B1 (pl) 2014-08-29
MXPA05004628A (es) 2005-09-08
ES2295660T3 (es) 2008-04-16
JP2006507295A (ja) 2006-03-02
CA2504872C (en) 2011-07-05
US8431617B2 (en) 2013-04-30
KR101060331B1 (ko) 2011-08-30
EP1567137B1 (en) 2007-12-26
TWI337863B (en) 2011-03-01
PT1567137E (pt) 2008-02-19
WO2004041260A1 (en) 2004-05-21
CA2504872A1 (en) 2004-05-21

Similar Documents

Publication Publication Date Title
ITRM20020562A1 (it) Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
AR037109A1 (es) Uso de flibanserina
LTC1425001I2 (lt) Fenetanolamino dariniai, skirti kvėpavimo ligoms gydyti
DE122011100049I1 (de) Stabile pharmazeutische Losungsformulierungen fur unter Druck stehende Inhaliergerate fur die Verabreichung abgemessener Dosen.
IS7076A (is) Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni
HRP20060240T3 (hr) Intranazalni pripravak rotigotina
CY1109880T1 (el) ΑΝΤΑΓΩΝΙΣΤΗΣ CaSR
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CL2009000980A1 (es) Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006).
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
EP1359927A4 (en) PHYTOPHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING IMMUNOLOGICAL DISEASES
ITRM20020492A0 (it) Uso della propionil l-carnitina per la preparazione di un medicamentoper il trattamento del glaucoma.
ECSP003551A (es) Complejo farmaceutico
CY1106129T1 (el) Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος
AR028970A1 (es) USO DE CILANSETRON O DE SUS SALES POR ADICIoN DE A CIDOS Y/O SOLVATOS FARMACOLoGICAMENTE COMPATIBLES PARA LA OBTENCIoN DE PREPARADOS FARMACEUTICOS PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL SíNDROME DEL INTESTINO IRRITABLE
ITRM20010293A0 (it) Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
ITRM20000433A0 (it) Uso di fibrati per la preparazione di un medicamento utile nel trattamento dell'insufficenza cardiaca congestizia.
ITRM20040288A1 (it) Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
ITMI20032067A1 (it) Formulazione spray per il trattamento delle infezioni virali.
IT1317836B1 (it) Uso del tiamfenicolo per la preparazione di composizioni farmaceuticheutili per il trattamento di infezioni da staphylococci
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
ITRM20010319A1 (it) Uso di una alcanoil l-carnitina per la preparazione di un medicamentoper il trattamento dell'anedonia.
SI1567137T1 (sl) Uporaba resveratrola za pripravo zdravila za uporabo pri zdravljenju infekcij z virusom influence
ITMI20011628A1 (it) Uso della nac per la preparazione di un medicamento adatto allasomministrazione endovenosa per il trattamento del fenomeno di